Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome.
Saved in:
| Title: | Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome. |
|---|---|
| Authors: | Chertow GM; Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Palo Alto, California, USA., Appel GB; Division of Nephrology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York, USA., Andreoli S; Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, Indiana, USA., Bangalore S; Cardiovascular Clinical Research Center, New York University School of Medicine, New York, New York, USA., Block GA; Department of Clinical Research and Medical Affairs, US Renal Care, Inc., Plano, Texas, USA., Chapman AB; Section of Nephrology, University of Chicago, Chicago, Illinois, USA., Chin MP; Department of Product Development, Reata Pharmaceuticals, Plano, Texas, USA., Gibson KL; University of North Carolina Kidney Center at Chapel Hill, Chapel Hill, North Carolina, USA., Goldsberry A; Department of Product Development, Reata Pharmaceuticals, Plano, Texas, USA., Iijima K; Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan., Inker LA; Division of Nephrology, Tufts Medical Center, Boston, Massachusetts, USA., Knebelmann B; Department of Nephrology, Necker Hospital, AP-HP, Université de Paris, Paris, France., Mariani LH; Department of Internal Medicine, Division of Nephrology, University of Michigan, Ann Arbor, Michigan, USA., Meyer CJ; Department of Product Development, Reata Pharmaceuticals, Plano, Texas, USA., Nozu K; Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan., O'Grady M; Department of Product Development, Reata Pharmaceuticals, Plano, Texas, USA., Silva AL; Boise Kidney and Hypertension Institute, Meridian, Idaho, USA., Stenvinkel P; Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Technology and Intervention, Karolinska Institutet, Stockholm, Sweden., Torra R; Inherited Kidney Disorders, Nephrology Department, Fundacio Puigvert, Instituto de Investigacion Carlos III, Universitat Autonoma de Barcelona, Barcelona, Spain., Warady BA; Division of Pediatric Nephrology, Children's Mercy Kansas City, Kansas City, Missouri, USA., Pergola PE; Renal Associates PA, San Antonio, Texas, USA. |
| Source: | American journal of nephrology [Am J Nephrol] 2021; Vol. 52 (3), pp. 180-189. Date of Electronic Publication: 2021 Mar 31. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Clinical Trial Protocol |
| Journal Info: | Publisher: Karger Country of Publication: Switzerland NLM ID: 8109361 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1421-9670 (Electronic) Linking ISSN: 02508095 NLM ISO Abbreviation: Am J Nephrol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
